Patients with T2D exhibit decreased butyrate-producing GM compared to healthy controls (28), leading to impaired glucose tolerance and insulin sensitivity due to decreased GPCR release of PYY and GLP-1 (28). Here, INS is linked to type 2 diabetes mellitus.